Relmada Therapeutics Inc (NAS:RLMD)
$ 3.53 -0.27 (-7.11%) Market Cap: 106.52 Mil Enterprise Value: 10.19 Mil PE Ratio: 0 PB Ratio: 1.24 GF Score: 31/100

Relmada Therapeutics Inc (RLMD) Stock Estimates Data

Relmada Therapeutics Inc (RLMD) 12 Month Price Targets

Relmada Therapeutics Inc (RLMD) Analyst Rating